GOLDMAN SACHS GROUP INC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 22 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2021$105,000
-55.9%
92,168
+14.9%
0.00%
Q2 2021$238,000
+510.3%
80,184
+615.7%
0.00%
Q1 2021$39,000
-95.9%
11,203
-94.4%
0.00%
Q4 2020$950,000
+787.9%
200,047
+508.6%
0.00%
Q2 2020$107,000
-29.1%
32,871
+32.1%
0.00%
Q2 2017$151,000
+259.5%
24,881
+138.0%
0.00%
Q3 2015$42,000
-32.3%
10,456
-16.6%
0.00%
Q2 2015$62,000
+44.2%
12,534
+14.3%
0.00%
Q4 2014$43,00010,9650.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,030,533$22,539,0004.01%
ARS Investment Partners, LLC 796,367$8,840,0001.41%
Gagnon Advisors, LLC 194,579$2,160,0001.37%
GAGNON SECURITIES LLC 263,894$2,929,0000.84%
Benchmark Capital Advisors 96,235$1,068,0000.81%
PERKINS CAPITAL MANAGEMENT INC 94,550$1,050,0000.75%
Cortina Asset Management, LLC 645,718$7,167,0000.34%
EAM Investors, LLC 73,327$814,0000.13%
Whitegate Investment Counselors, Inc. 11,000$122,0000.02%
ROYCE & ASSOCIATES LP 299,353$3,323,0000.02%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders